Clinical Trial Update: Effectiveness and Safety of Lidocaine for Scleroderma [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluated the effectiveness and safety of lidocaine for systemic sclerosis (scleroderma) and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Lidocaine (Lidocaine)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Scleroderma | Phase 2, Phase 3 | Status: COMPLETED